In a significant leap forward for cancer treatment in Monaco, the Centre Hospitalier Princesse Grace (CHPG) has unveiled two groundbreaking advancements in radiotherapy. The new acquisitions promise to revolutionise patient care, particularly for those with skin cancer.

Timed to coincide with World Cancer Day on 4th February, the unveiling of the CHPG’s latest innovations earlier this month underscores the establishment’s commitment to improving cancer treatment in the Principality.

The first addition to the hospital is a cutting-edge surface radiotherapy system, which enhances precision in radiation therapy, minimising damage to surrounding healthy tissue. The second is an advanced treatment device specifically designed for skin cancer cases previously considered inoperable due to medical constraints.

These state-of-the-art technologies are part of a broader initiative spearheaded by the CHPG’s Skin Tumour Centre that aims to streamline patient access to specialised dermatological care. By integrating these advancements into its cancer treatment pathway, CHPG is further strengthening its position as a leader in medical innovation and patient-centred care.

The unveiling ceremony on 3rd February was attended by key dignitaries from Monaco, including Secretary of State Yvette Lambin-Berti, Minister of Social Affairs and Health Christophe Robino and CHPG Board Chair Caroline Rougaignon-Vernin. Also present were Vice President of the Board Robert Chanas, CHPG Director Benoîte Rousseau de Sevelinges and Radiotherapy Service Head Dr. Cécile Ortholan. Notably, philanthropist Lord Laidlaw, whose generous donation helped make these advancements possible, was also in attendance.

Read related:

CHPG’s Gerontology Clinic welcomes new therapy dog to the team